Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • A study of EP0031 and drug combination for patients with advanced cancers having changes in the RET gene

    Recruiting

    1 1 1
    France Germany Italy Poland Spain
  • Comparison of two doses of cabozantinib (60 mg vs 140 mg) in patients with progressive metastatic medullary thyroid cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Croatia Hungary Poland Romania
  • Study on the Effects of Selpercatinib in Patients Aged 12 and Older with Advanced Solid Tumors with RET Gene Alteration

    Not recruiting

    1 1 1
    Investigated drugs:
    Denmark France Germany Italy Spain
  • Study Comparing Selpercatinib, Cabozantinib, and Vandetanib for Patients with Advanced RET-Mutant Medullary Thyroid Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Belgium Czechia France Germany Greece Italy +3
  • Study on the Effects of Selpercatinib in Children with Advanced RET-Altered Solid Tumors or Primary Central Nervous System Tumors

    Not recruiting

    1 1 1
    Investigated drugs:
    Denmark France Germany Italy Spain
  • Study on Selpercatinib for Adults with Advanced or Metastatic Solid Tumors with RET Activation

    Not recruiting

    1 1 1 1
    Investigated drugs:
    France Italy Poland Spain